Denali Therapeutics Inc. (DNLI)

USD 12.5

(-0.04%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.15 Billion 1.46 Billion 1.4 Billion 1.6 Billion 553.23 Million 661.98 Million
Total Current Assets 1.06 Billion 1.37 Billion 897.23 Million 1.49 Billion 430.03 Million 480.83 Million
Cash And Short Term Investments 1.03 Billion 1.33 Billion 865.4 Million 1.46 Billion 415.35 Million 464.29 Million
Cash and Cash Equivalents 127.1 Million 218.04 Million 293.47 Million 507.14 Million 79.44 Million 77.12 Million
Short Term Investments 907.4 Million 1.11 Billion 571.93 Million 962.55 Million 335.9 Million 387.17 Million
Net Receivables 2.7 Million 5 Million 1.22 Million 5.67 Million - 8.54 Million
Inventory 1.00 -5 Million - - - -8.54 Million
Other Current Assets 26.92 Million 36.1 Million 30.6 Million 20.28 Million 14.67 Million 16.53 Million
Total Non-Current Assets 89.77 Million 87.92 Million 506.92 Million 108.62 Million 123.2 Million 181.14 Million
Net PPE 71.63 Million 74.52 Million 69.6 Million 73.46 Million 80.65 Million 25.16 Million
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 1.6 Million 1.5 Million 425.44 Million 32.69 Million 39.88 Million 147.88 Million
Tax Assets - - - - - -
Other Non Current Assets 16.54 Million 11.89 Million 11.87 Million 2.46 Million 2.65 Million 8.1 Million
Other Assets 1.00 - - - - -
Total Liabilities 122.96 Million 417.81 Million 441.87 Million 453.74 Million 158.34 Million 115.13 Million
Total Current Liabilities 77.98 Million 363.92 Million 378.24 Million 71.69 Million 45.34 Million 32.78 Million
Account Payables 9.48 Million 2.79 Million 4.77 Million 1.07 Million 2.59 Million 1.89 Million
Tax Payables - - - - - -
Short Term Debt 7.26 Million 7.31 Million 5.45 Million 4.69 Million 3.66 Million 19.08 Million
Deferred Revenue - 290.05 Million 320.3 Million 23.48 Million 18.73 Million 11.42 Million
Other Current Liabilities 61.23 Million 63.76 Million 47.71 Million 42.45 Million 20.35 Million 380 Thousand
Total Non Current Liabilities 44.98 Million 53.89 Million 63.62 Million 382.05 Million 112.99 Million 82.35 Million
Long-Term Debt 44.98 Million 53.03 Million 58.55 Million 64.17 Million 68.86 Million -
Deferred Revenue Non Current - 479 Thousand 4.69 Million 317.17 Million 43.75 Million 57.35 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -1.00 379 Thousand 379 Thousand 701 Thousand 379 Thousand 25 Million
Other Liabilities 1.00 - - - - -
Total Equity 1.03 Billion 1.04 Billion 962.29 Million 1.15 Billion 394.89 Million 546.84 Million
Stock Holders Equity 1.03 Billion 1.04 Billion 962.29 Million 1.15 Billion 394.89 Million 546.84 Million
Common Stock 1.71 Million 1.68 Million 1.54 Million 1.53 Million 1.28 Million 1.27 Million
Retained Earnings -1.11 Billion -970.98 Million -644.99 Million -354.41 Million -425.55 Million -227.93 Million
Accumulated other comprehensive income 643 Thousand -6.88 Million -2.49 Million -245 Thousand 350 Thousand -649 Thousand
Common Stock Equity 1.03 Billion 1.04 Billion 962.29 Million 1.15 Billion 394.89 Million 546.84 Million
Capital Lease Obligation 44.98 Million 60.35 Million 58.55 Million 64.17 Million 68.86 Million -
Total Investments 909 Million 1.11 Billion 997.37 Million 995.25 Million 375.79 Million 535.05 Million
Total Debt 52.24 Million 60.35 Million 58.55 Million 64.17 Million 68.86 Million -
Net Debt -74.86 Million -157.69 Million -234.92 Million -442.96 Million -10.58 Million -77.12 Million

Balance Sheet Charts